{"filing":{"accession_number":"0001654954-26-006951","cik":"0001131399","ticker":"GLAXF","company_name":"GSK plc","form":"6-K","filing_date":"2026-07-28","report_date":"2026-07-28","primary_document":"a1904o.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1131399/000165495426006951/a1904o.htm"},"events":[{"id":20994,"run_id":18918,"accession_number":"0001654954-26-006951","anchor_item_number":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"GSK announces positive Phase III trial results (ARTEMIS-011) for Ris-Rez in relapsed osteosarcoma, meeting its primary endpoint of progression-free survival. This is a material clinical development milestone for a key oncology asset with FDA Breakthrough Therapy Designation, demonstrating efficacy across multiple tumor types and supporting GSK's broader development program. The disclosure is operational/strategic rather than a discrete financial event, earnings release, or executive action.","company_name":"GSK plc","ticker":"GLAXF","filing_date":"2026-07-28","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":20520,"accession_number":"0001654954-26-006951","item_number":null,"item_title":null,"event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"GSK announces positive Phase III trial results (ARTEMIS-011) for Ris-Rez in relapsed osteosarcoma, meeting its primary endpoint of progression-free survival. This is a material clinical development milestone for a key oncology asset with FDA Breakthrough Therapy Designation, demonstrating efficacy across multiple tumor types and supporting GSK's broader development program. The disclosure is operational/strategic rather than a discrete financial event, earnings release, or executive action.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-28T17:04:38.937121+00:00","company_name":"GSK plc","ticker":"GLAXF","filing_date":"2026-07-28"}]}